EXC Stock

Business

Mineralys Therapeutics Submits New Drug Application for Hypertension Treatment Lorundrostat, Backed by Strong Clinical Data

Clinical-stage biopharma Mineralys Therapeutics has filed its New Drug Application for lorundrostat, a potential treatment for resistant hypertension, following positive results from multiple trials. The move positions the company for a potential 2026 market entry and has drawn upgraded price targets from analysts.

Jan 30, 2026

Business

Bank of America Bullish on Apellis, Upgrades to 'Buy' on Strong Drug Launch and Kidney Disease Prospects

Bank of America has upgraded Apellis Pharmaceuticals (APLS) to 'Buy,' citing robust early adoption of its drug Empaveli and significant undervaluation of its potential in treating rare kidney diseases, despite a more cautious outlook from Wells Fargo.

Jan 30, 2026

Business

Mizuho Lifts SanDisk Target to $600, Citing NAND Supply Crunch and AI-Driven Demand Surge

Mizuho Securities dramatically raised its price target on SanDisk, forecasting a severe NAND flash memory shortage driven by explosive AI server demand and constrained production capacity through 2027.

Jan 30, 2026

Business

DigitalOcean Soars as 'Clawdbot' AI Assistant Drives Analyst Optimism and Price Target Hikes

Bank of America leads a wave of analyst upgrades for DigitalOcean, citing the viral success of its AI agent 'Clawdbot' and the company's strategic positioning in the burgeoning agentic AI market for developers.

Jan 30, 2026

Business

Analysts Bullish on Core Scientific's AI Pivot, Price Targets Raised

Wall Street firms Keefe Bruyette and BTIG have raised price targets on Core Scientific, citing the company's strategic shift from Bitcoin mining to high-performance computing infrastructure for AI as a key driver for future growth.

Jan 30, 2026

Business

Barclays Taps Astera Labs as Key AI Infrastructure Bet for 2026, Sees Quality Firms Leading the Pack

Barclays raises Astera Labs' price target to $165, naming it a top pick for AI integration plays in its 2026 semiconductor outlook, while contrasting analyst views highlight the evolving debate on AI's infrastructure demands.

Jan 30, 2026

Business

Hutchison Port Holdings Trust Sees Efficiency Gains, But Can Its ROCE Momentum Hold?

The Singapore-listed port operator has significantly improved its capital efficiency over five years, rewarding shareholders. Analysts are now weighing whether this trend is sustainable for long-term growth.

Jan 30, 2026

Business

Analysts See Deep Value in Corero Network Security, Suggesting Shares Could Be Undervalued by Over 40%

A new discounted cash flow analysis indicates Corero Network Security plc (LON:CNS) may be significantly undervalued at current trading levels, presenting a potential opportunity for investors in the cybersecurity sector.

Jan 30, 2026

Business

Microsoft's AI Spending Spree Sends Shockwaves Through Markets, Dragging Tech Sector Into Bear Territory

A sharp sell-off in Microsoft shares following its earnings report has ignited fresh fears over the profitability of massive AI investments, pulling major indexes lower and pushing the software sector into a bear market.

Jan 30, 2026

Business

Australia Vows to Press Ahead with Critical Minerals Strategy Despite U.S. Policy Shift

Australia reaffirms its commitment to building resilient critical mineral supply chains and a strategic reserve, undeterred by the U.S. stepping back from plans to guarantee minimum prices for such projects.

Jan 30, 2026

Business

Bango's Turnaround: From Losses to Profitability as Capital Efficiency Rises

The UK-based payments technology firm Bango (LON:BGO) is showing early signs of a financial transformation, breaking into profitability and increasing its capital deployment. While its return on capital remains below the software industry average, the underlying trend suggests a company in the midst of a strategic pivot.

Jan 30, 2026

Business

ResMed Posts Strong Q2 Growth on New Product Momentum and GLP-1 Therapy Tailwinds

ResMed Inc. reports an 11% revenue surge for its second fiscal quarter, driven by robust mask sales and strategic acquisitions, while navigating competitive pressures and capitalizing on emerging healthcare trends.

Jan 30, 2026

Business

Stryker Caps Record Year with Strong Q4, Bullish on 2026 Despite Market Headwinds

The medical technology giant reports double-digit organic sales growth for the fourth consecutive year, driven by its Mako robotic system and strategic leadership shifts, while navigating tariffs and a shifting competitive landscape.

Jan 30, 2026

Business

OSI Systems Beats Expectations, Raises Outlook Despite Sector Headwinds

OSI Systems posts record Q2 revenue and lifts full-year EPS guidance, navigating softness in security bookings and healthcare challenges with optimism for a stronger second half.

Jan 30, 2026

Business

GSI Technology Posts Q3 Revenue Growth Amid Strategic Pivot to Defense and Edge AI

GSI Technology Inc. reports a 12% year-over-year revenue increase for Q3 2026, driven by defense sector adoption of its Gemini-II APU. While R&D investments pressure margins, the company highlights a strong cash position and expanding applications in smart cities and robotics.

Jan 30, 2026

Business

KLA Navigates Supply Chain Headwinds to Post Record Revenue, Eyes 2027 for Advanced Packaging Surge

KLA Corporation reports robust fiscal 2025 results driven by AI demand, but warns of supply constraints and geopolitical factors tempering near-term growth, with a significant acceleration projected for late 2026 and 2027.

Jan 30, 2026

Business

Schneider National Charts Course Through Market Headwinds, Eyes Long-Term Growth Despite Q4 Challenges

Facing a tough freight environment, Schneider National's leadership outlines a strategy centered on cost discipline, tech investment, and strategic positioning in intermodal and dedicated services to steer toward future profitability.

Jan 30, 2026

Business

MaxLinear Posts Strong Q4 Revenue on Infrastructure Surge, Navigates Broadband Transition

MaxLinear Inc. reported a 48% year-over-year revenue jump for Q4 2025, powered by its infrastructure business, even as it manages a near-term dip in broadband and intensifying competition in key markets.

Jan 30, 2026

Business

KeyCorp Posts Strong Q4 Earnings and Announces Capital Moves, But Core Bull Thesis Remains Unchanged

KeyCorp's latest quarterly results beat expectations, fueled by higher net interest income and a return to full-year profitability. The regional bank also completed a $200 million share buyback and issued $750 million in new debt, while refreshing its board. Analysts suggest these moves fine-tune the bank's strategy rather than radically alter its investment narrative.

Jan 30, 2026

Business

SThree Announces June Dividend, But Sustainability Questions Linger

Specialist recruiter SThree plc confirms a £0.092 per share dividend payment in June, offering a headline yield of 7.5%. While cash flow coverage appears robust, analysts point to a history of payout instability and stagnant earnings as causes for investor caution.

Jan 30, 2026